Protecting Livestock. Improving Human Lives

Evaluation of a combined live attenuated vaccine against Lumpy skin disease, contagious bovine pleuropneumoniae and Rift Valley Fever

Author: Zohra Bamouh , Amal Elarkam , Soufiane Elmejdoub , Jihane Hamdi , Zineb Boumart , Greg Smith , Matthew Suderman , Mahder Teffera , HezronWesonga , Stephen Wilson , Douglas M. Watts , Shawn Babiuk , Brad Pickering and Mehdi Elharrak

Year: 2024

About this Publication:

The use of effective vaccines is among the most important strategies for the prevention and progressive control of transboundary infectious animal diseases. However, the use of vaccine is often impeded by the cost, a lack of cold chains and other factors. In resource-limited countries in Africa, one approach to improve coverage and reduce cost is to vaccinate against multiple diseases using combined vaccines. Therefore, the objective of this study was to evaluate a combined vaccine for the prevention and control of Lumpy Skin Disease (LSD), Contagious Bovine Pleuropneumonia (CBPP) and Rift Valley fever (RVF). The LSD and CBPP were formulated as a combined vaccine, and the RVF was formulated separately as live attenuated vaccines.

Grant: VITAL

Subject Areas: Research and Development

Diseases: Contagious Bovine Pleuropneumonia, Rift Valley Fever, Lumpy Skin Disease



Antibody, Contagious bovine pleuropneumonia (CBPP), Rift Valley Fever, Vaccine, cattle, immunogenicity, lumpy skin disease, efficacy

Download Publication (PDF)